合并桥本氏甲状腺炎对甲状腺癌发生发展影响的研究进展
摘要
关键词
全文:
PDF参考
Vargas-Uricoechea H, Nogueira J P, Pinzón-Fernández M V, et al. The usefulness of thyroid antibodies in the diagnostic approach to autoimmune thyroid disease[J]. Antibodies, 2023,12(3):48.
Swan K Z, Madsen S H, Bonnema S J, et al. Preoperative BRAFV600E mutation detection in thyroid carcinoma by immunocytochemistry[J]. Apmis, 2022,130(11):627-636.
LEE J-H, KIM Y, CHOI J-W, et al. The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis [J]. European journal of endocrinology, 2013,168(3).
Xu J, Ding K, Mu L, et al. Hashimoto’s Thyroiditis: A Double-Edged Sword in Thyroid Carcinoma[J]. Front Endocrinol (Lausanne), 2022(13):801925.
Konturek A, Barczyński M, Wierzchowski W, et al. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis[J]. Langenbeck’s archives of surgery, 2013(398):389-394.
Tomer Y. Anti-thyroglobulin autoantibodies in autoimmune thyroid diseases: cross-reactive or pathogenic?[J]. Clin Immunol Immunopathol, 1997,82(1):3-11.
Rebuffat S A, Nguyen B, Robert B, et al. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease[J]. The Journal of Clinical Endocrinology & Metabolism, 2008,93(3):929-934.
Rhoden K J, Unger K, Salvatore G, et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto’s thyroiditis share low-level recombination events with a subset of papillary carcinoma[J]. The Journal of Clinical Endocrinology & Metabolism, 2006,91(6):2414-2423.
Chen D, Zhang X, Li Z, et al. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages[J]. Theranostics,2021,11(3):1016.
Morris L G T, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis[J]. The American journal of surgery, 2010,200(4): 454-461.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i10.21664
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。